Deirdre OlynickPhD, MBA
Dr. Olynick joined ATOM, a consortium for AI-driven drug discovery, at its founding in October 2017 as Head of Business Development and Operations. At ATOM, Dr. Olynick is responsible for creating high-value public-private partnerships and understanding the AI, data, and experimental landscape that will drive the future of early drug discovery. In the data space, Dr. Olynick has been working with the ATOM team to enable the AI community with sharable curated and newly generated drug discovery data. Dr. Olynick has an MBA from Wharton and a Ph.D. in Materials Science and Engineering from the University of Illinois at Urbana-Champaign.